Vierhoefen, Germany

Theo Schotten

This inventor holds 27 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Eli Lilly and Company, Beiersdorf-Lilly Gmbh, Beiersdorf Ag. Active years: 1991-2024.

USPTO Granted Patents = 27 

% Patents Active = 74.1

 

Average Co-Inventor Count = 5.8

ph-index = 9

Forward Citations = 278(Granted Patents)


Location History:

  • Vierh ofen, DE (1996 - 1997)
  • Vierhufen, DE (2002 - 2007)
  • Vierhoefen, DE (1998 - 2019)
  • Hamburg, DE (1991 - 2024)

Company Filing History:


Years Active: 1991-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Zwitterionic Nanoparticles
Polymer Micelles
Melanin Concentrating Hormone Antagonists
3-Substituted Oxindole
Spiro Compounds
Glycoprotein IIb/IIIa Antagonists
Hypoglycemic Compounds
Pyrimidine Compounds
Protein Kinase C Inhibitors
Novel Benzopyran Derivatives
Diabetes Treatment
Obesity Treatment
27 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Theo Schotten

Introduction

Theo Schotten, based in Vierhoefen, Germany, is a notable inventor with a remarkable portfolio of 27 patents. His work primarily focuses on advancements in nanoparticle technology, significantly impacting various fields, including pharmaceuticals and materials science.

Latest Patents

Among his latest innovations are groundbreaking patents that include zwitterionic nanoparticles. This invention involves a zwitterionic nanoparticle consisting of at least one nanoparticle encased in a zwitterionic shell. The patent also covers associated compositions, methods for binding these nanoparticles, and their applications in various contexts. Another significant patent is centered on polymer micelles containing nanoparticles in non-aqueous solutions. This invention details a composition featuring micelles that encapsulate nanoparticles while possessing a cross-linked hydrophilic shell, along with methods for their preparation and use.

Career Highlights

Theo has had an extensive career with significant contributions to innovative companies such as Eli Lilly and Company and Beiersdorf-Lilly GmbH. His work has propelled developments in drug formulation and delivery systems, demonstrating his commitment to advancing medical science through innovative technologies.

Collaborations

Schotten has collaborated with talented professionals in the field, including Wolfgang Stenzel and Michael Paal. These collaborations have fostered a rich environment for innovation, leading to the successful development of several patented technologies.

Conclusion

Theo Schotten's contributions to the field of nanoparticle technology are invaluable. His extensive portfolio of patents showcases his innovative spirit and dedication to improving technological applications across various industries. As advancements continue in this area, Theo's work remains a significant influence in shaping future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…